Literature DB >> 17317049

Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.

M Hamidi1, N Zarei, A H Zarrin, S Mohammadi-Samani.   

Abstract

Erythrocytes as the most readily available and abundant cells within the body, have been studied extensively for their potential application as drug delivery carriers. In this study, human erythrocytes have been loaded by bovine serum albumin (BSA) as a model antigen/protein using hypotonic preswelling method for targeted delivery of this antigen to antigen-presenting cells (APCs). A series of in vitro tests have been carried out to characterize the carrier cells in vitro, including loading parameters, BSA and hemoglobin release kinetics, hematological indices, particle size distribution, SEM analysis, osmotic and turbulence fragility, and osmotic competency. BSA was loaded in erythrocytes with a loaded amount of 1.98+/-0.009mg with antigen release from carrier cells showing a zero-order kinetic consistent to that of the cell lysis. The apparent cell sizes, measured using laser scattering, were not significantly different from normal erythrocytes, but the real sizes, measured using SEM, and surface topologies were quite different between loaded and unloaded cells. The BSA-loaded cells were remarkably more fragile and less deformable compared to the normal cells. Totally, BSA-loaded erythrocytes seem to be a promising delivery system for reticuloendothelial system (RES) targeting of the antigens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317049     DOI: 10.1016/j.ijpharm.2007.01.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Whole blood cells loaded with messenger RNA as an anti-tumor vaccine.

Authors:  Kyle K L Phua; David Boczkowski; Jens Dannull; Scott Pruitt; Kam W Leong; Smita K Nair
Journal:  Adv Healthc Mater       Date:  2013-12-16       Impact factor: 9.933

2.  Simulation of the osmosis-based drug encapsulation in erythrocytes.

Authors:  Duobiao Ge; Lili Zou; Chengpan Li; Sen Liu; Shibo Li; Sijie Sun; Weiping Ding
Journal:  Eur Biophys J       Date:  2017-09-20       Impact factor: 1.733

3.  Engineering of erythrocyte-based drug carriers: control of protein release and bioactivity.

Authors:  Rongcong Luo; Shaillender Mutukumaraswamy; Subbu S Venkatraman; Björn Neu
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

Review 4.  A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles.

Authors:  Liang Pang; Chun Zhang; Jing Qin; Limei Han; Ruixiang Li; Chao Hong; Huining He; Jianxin Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study.

Authors:  Gamal El-din I Harisa; Mohamed F Ibrahim; Fars K Alanazi
Journal:  Int J Med Sci       Date:  2011-03-11       Impact factor: 3.738

6.  Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer.

Authors:  Gamaleldin I Harisa; Mohamed M Badran; Saeed A AlQahtani; Fars K Alanazi; Sabry M Attia
Journal:  Saudi Pharm J       Date:  2015-03-21       Impact factor: 4.330

Review 7.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

8.  Rainbow Trout Erythrocytes ex vivo Transfection With a DNA Vaccine Encoding VHSV Glycoprotein G Induces an Antiviral Immune Response.

Authors:  Sara Puente-Marin; Ivan Nombela; Veronica Chico; Sergio Ciordia; Maria Carmen Mena; Julio Coll; Luis Mercado; Maria Del Mar Ortega-Villaizan
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

9.  Potential Role of Rainbow Trout Erythrocytes as Mediators in the Immune Response Induced by a DNA Vaccine in Fish.

Authors:  Sara Puente-Marin; Ivan Nombela; Veronica Chico; Sergio Ciordia; Maria Carmen Mena; Luis Garcia Perez; Julio Coll; Maria Del Mar Ortega-Villaizan
Journal:  Vaccines (Basel)       Date:  2019-07-03

10.  Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment.

Authors:  Zhongyao Cheng; Siyu Liu; Xinyi Wu; Faisal Raza; Yichen Li; Weien Yuan; Mingfeng Qiu; Jing Su
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.